CRS 2008 Election Results
The CRS election was overflowing with outstanding candidates. Your votes have been tallied. Read more to learn the election results.

Read More

The growth of the Journal of Controlled Release (JCR) for the last several years has been outstanding, thanks to its authors, reviewers, and readers. The editors of JCR have been working to make the whole process of publication easier and more pleasant for the authors. Recently, we decided to make two important changes. JCR is updating aspects of the manuscript submission process and the publication format.

Read More

The CRS Newsletter is published four times a year and sent free to all members of the CRS. With the Newsletter, we aim to help keep our membership informed about research, news, and forthcoming events in the field of controlled release and delivery of bioactives. The Newsletter accepts unsolicited topical and concise articles which are of broad interest to scientists working in the area of drug delivery.

Read More

The CRS Committees are made of a huge cast of characters from around the world. Let's get to know Mike Rathbone, the newly appointed Chair of the CRS Books Sub-committee.

Read More

Are you looking for a specific CRS Committee?

Read More

The CRS Exposition is the venue for the business of bioactive delivery and profitable collaborations. Attendees come to learn the latest advances in delivery and dissolution technologies, instrumentation, equipment, processing innovations, contract services and more. Many exhibitors are longtime partners and pioneers in the field of controlled release. Other exhibitors are introducting themselves for the firt time, offering new ideas, new products, and new services. Come to the Exposition and discover new opportunities.

Read More

Funding the CRS activities elevates you and your company in the eyes and ears of the attending professionals. Sponsorship dollars assist in underwriting the cost of networking and programming, along with covering expenses on services offered and items provided to attendees. In addition to the recognition donors receive with each specific event or item sponsored, CRS offers extra benefits, such as annual meeting complimentary registrations, educational workshop complimentary registrations, and complimentary exhibit space.

Read More

CRS is also exploring ways to support its members through the newly created CRS Foundation. Immediate Past President Randy Mrsny started the necessary work to begin the new CRS Foundation, the mission of which is to provide a durable source of financial support for the advancement of educational and organizational activities that enrich and extend the research and development of CR-associated technologies. Just as Randy passed the gavel to me in Long Beach, the same type thing has happened with the CRS Foundation. It's now my turn to work diligently to further the causes of the CRS Foundation. Examples of such activities include set up and support of fellowships, lectures, and awards honoring individuals who have made notable advances in the areas of CRS related to bioactive delivery technologies.

Read More

The CRS Bioactive Materials track has much to offer. If you are a scientist starting out and wondering where to pitch your tent, this is the society and meeting for you.

Read More

The Consumer and Diversified Products (C&DP) is a track within CRS that is focused on controlled release of active ingredients in non-pharmaceutical applications. This track has traditionally involved food, nutritional, nutraceutic, cosmetic, cosmeceutic, consumer product, agricultural, chemical, and other applications and industries, but is open to all non-pharmaceutical work.

Read More

The Veterinary Track has a wealth of experience in diverse areas of animal health, including companion animal dosage forms, bioactive delivery to livestock, regulatory issues for animal health, veterinary medicine, imaging of dosage forms, formulation issues, in vitro and in vivo assessment of dosage forms, animal model development, animal vaccines, intraruminal formulations, intramammary formulations, transmucosal vaccination, animal models, providing target species data on bioactive materials in a timely manner, vaccine formulation and testing, and vaginal delivery of hormones. Hot topics of discussion in the Vet group are development of dosage forms that are capable of releasing bioactivites for a duration of days to years, influence of in vivo physiological characteristics on dosage form performance attributes, critical manufacturing avriables and design space of parenteral products, and novel release technologies.

Read More